the definition of the future of functional and regenerative medicine. In search of these pathfinders, IPHA celebrates some of the top role models of our day! These solutionists are the next modelers of the non-invasive movement in integrative healthcare. One such visionary is Mr. CHARLES VORWALLER, American Health Innovator and the brainsmith behind Aspen Laser and the Theralight series.
Our 2023 search brought us together with a remarkable advancement in red light therapy by a company called Aspen Laser (See event report on March 7, 2023) where a Demo Day with their rep was a great success. Shortly after the event, a heartfelt thanks and congratulatory letter was sent to CEO and founder Mr. Charles Vorwaller for a fantastic product. A stunning surprise was granted us directly by Mr. Vorwaller who immediately booked a flight to NYC to see us. With a growing set of clues about the strength behind this company (and their truly fearless leader), his energy and enthusiasm to connect aligned with the INC5000 list of fastest growing privately owned companies in 2020. Headlines reported Aspen Laser was the only medical laser company on the list. In 202I, it received a five-year GSA contract to sell to VA hospitals. 
Setting the industry standard, the TheraLight 360 uses patent pending technologies that ensure tissue saturation regardless of skin color or body type. He brought major spotlight to the scientific term (and treatment modality) "Photobiomodulation Therapy" - the application of Red and Near Infrared light to tissue that is injured, sick or degenerating to increase circulation, increase cellular energy production, reduce inflammation and reduce Oxidative Stress. His original vision that began in 1988 over 35 years ago was to redefine Pain Management and Recovery that resulted in the startup in 2014 for a new company called ASPEN LASER. It grew to become a leading edge nonpharmacologic technology and research based products that make a difference in the lives of individuals (including animals) suffering from pain and injury. Mr. Vorwaller's initial focus to accomplish this was through innovative development and breakthrough advancement with lasers providing High Intensity Laser Therapy, incorporating technologies with multiple power levels, multiple wavelengths and multiple operating modes.
"Since our company began, our focus has been on developing leading-edge technology in laser therapy," said Mr. Vorwaller. "Our medical lasers represent a number of technological developments that are significantly different than other lasers and light therapy products in the market... which we found to not be very effective". The result of his passion and never-ending pursuit for optimal outcomes has resulted in products delivering new treatment options providing higher dosages, more treatment areas and overall faster treatment times and accelerated healing and recovery.
In an exclusive interview with Mr. Vorwaller, he shared a candid look at where it all began for him. The roots to all of his work was heavily inspired by his Dad (Charles J. Vorwaller, LCSW), a 60+ year veteran and recognized visionary leader in the non profit mental health industry.
As a young boy, Charles witnessed firsthand the individuals that were undergoing treatment. They were sufferers of mental diseases and all the challenges that come from that. He witnessed his father develop and pursue forward thinking strategies and programs including therapeutic treatments and modalities beyond the traditional and limited drug-focused programs and protocols, with the incorporation of newer standards, including non-pharmaceutical and non-invasive based treatments and interventions. This humbled him greatly to see that his dad explored all options to help the sufferers when no one could help them. Charles grew up wanting to help the underserved and built this road in health technology. Looking back, Charles Vorwaller is convinced that his laser and red light therapy innovations contributed to mobilizing the science of patient care and impacted others by offering improved quality of life and in some cases, giving people a new chance at life."
In our continued search for the next voice in support of Integrative and Functional wellness, our editors opted to follow the trail of innovative (or "alternative") healing technologies to the doorsteps of those who truly believe in their benefits. In this case, an early report featuring Dr. Jennifer Stagg and her use of the THERALIGHT 360 prompted us to meet other therapists to get more insight in its clinical uses.
FROM THE BRAIN HEALTH COLLABORATIVE
11/18/2022- RED LIGHT THERAPY FOR TBI (By: Jennifer Stagg, ND) Within the past decade, ads for Red Light Therapy (RLT) devices have exponentially appeared in the health, wellness and commercial markets- drawing significant attention to their claims and challenging their efficacy. As with all technologies, many variables are to be considered as far as concluding on their proposed health benefits. Published reports from clinical (valid) studies detailing the utility of RLT in human health. Encouraging reviews indicate that there is a growing body of evidence for the use of RLT in traumatic brain injury (TBI) and neurodegenerative processes, including Stroke and Parkinson’s disease.
# # #
RED LIGHT THERAPY FOR TBI: by Dr. Jennifer Stagg
’Infrared’ refers to a type of light that is below the spectrum of visible light. The naked eye cannot see this type of light. Light is measured in wavelengths, and to further define infrared, there are near infrared (NIR) and far infrared (FIR) wavelengths. FIR is what is typically found in many of the devices sold to the general public like infrared blankets and saunas. (Although, saunas, combine heat with light so the effects of FIR are not comparable.) FIR offers some mild effects, but it doesn’t penetrate the body as much as NIR. As a result, most clinical research published to date is on visible red/NIR because these have been shown to be more effective. (See full review)
|Check out our sponsor|
POST-COVID BRAIN FOG & WORK PERFORMANCE
Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.